Clinical Trial Update: PRV-015 in Gluten-free Diet Non-responsive Celiac Disease [Phase 2]

View source ↗

Summary

Phase 2 study of PRV-015 in gluten-free diet non-responsive celiac disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• PRV-015 (PRV-015)

Snippet

Sponsor: Provention Bio, a Sanofi Company | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-10-20